Jim Cramer on Kimberly-Clark: “I Think Michael Hsu Is Doing a Fantastic Job With What the Hand He’s Got”

Core Viewpoint - Kimberly-Clark Corporation is actively pursuing a nearly $49 billion acquisition of Kenvue, which is seen as a bold move given Kenvue's stock has significantly decreased since its public offering [2] Group 1: Company Overview - Kimberly-Clark Corporation manufactures personal care products, including diapers, wipes, feminine and incontinence care products, and household paper goods [2] - The company's notable brands include Huggies, Kotex, Depend, Kleenex, Scott, and Cottonelle [2] Group 2: Acquisition Details - The planned acquisition of Kenvue includes its well-known over-the-counter products such as Tylenol, Band-Aids, and Aveeno [2] - Concerns have been raised regarding the potential risks associated with Kenvue, particularly related to Tylenol and its alleged links to autism, as mentioned by the Secretary of Health and Human Services [2] Group 3: Market Perspective - Jim Cramer highlighted that the weakness in Kimberly-Clark's stock may be more related to Kenvue's issues rather than Kimberly-Clark itself [1] - The company currently offers a 5% yield and is trading at 13 times earnings, which Cramer finds intriguing [1]